BNP Paribas Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2K Sell
407
-136
-25% -$6.45K ﹤0.01% 2078
2026
Q1
$28K Buy
543
+148
+37% +$10.4K ﹤0.01% 1922
2025
Q4
$36K Buy
395
+111
+39% +$10.6K ﹤0.01% 1764
2025
Q3
$21K Hold
284
– – ﹤0.01% 1371
2025
Q2
$37K Buy
+284
New +$41.2K ﹤0.01% 1244

Other funds holding INSP

BNP Paribas Asset Management's INSP Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Inspire Medical Systems (INSP) stake by 25% in Q2 2026, selling an estimated $6.45K and leaving 407 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2078.

BNP Paribas Asset Management first reported a position in INSP in Q2 2025 and has held it in 5 quarters since. The position peaked at $37K in Q2 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • BNP Paribas Asset Management held 407 shares of Inspire Medical Systems worth $18.2K as of Q2 2026.
  • BNP Paribas Asset Management sold 136 Inspire Medical Systems shares in Q2 2026, an estimated $6.45K.
  • Inspire Medical Systems made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2078 holding.
  • BNP Paribas Asset Management first reported a position in Inspire Medical Systems in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Inspire Medical Systems position peaked at $37K in Q2 2025.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.